Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

InsightRx

InsightRx
2015 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$9.8M LATEST DEAL AMOUNT
15 INVESTORS
Description

Developer of an online clinical analytics platform designed for precision dosing and clinical analytics. The company's platform provides an individualized understanding of a patient's response to treatment by using the principles of quantitative pharmacology and machine learning, enabling medical professionals to improve treatment effectiveness and provide direct benefit to patients.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Primary Office
  • 548 Market Street
  • Suite 88083
  • San Francisco, CA 94104
  • United States

+1 (205) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore InsightRx’s full profile, request a free trial.

InsightRx Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Early Stage VC (Series A) 20-Sep-2019 $9.8M 000.00 000.00 Completed Generating Revenue
9. Accelerator/Incubator 28-Jun-2018 00.000 Completed Generating Revenue
8. Grant 05-Jun-2018 0000 00.000 Completed Generating Revenue
7. Accelerator/Incubator 14-Dec-2017 00.000 Completed Generating Revenue
6. Early Stage VC (Series A) 23-May-2017 00.000 00.000 00.000 Completed Startup
5. Accelerator/Incubator 23-May-2017 00000 Completed Startup
4. Accelerator/Incubator 13-Feb-2017 00000 Completed Startup
3. Accelerator/Incubator 27-Jun-2015 00000 00000 Completed Startup
2. Accelerator/Incubator 27-Jun-2015 $390K Completed Startup
1. Seed Round 14-Apr-2015 $390K $390K 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

InsightRx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A-3 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A-2 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
Series A 23,007,313 $0.000100 $0.01 $0.14 $0.14 1x $0.14 22.52%
Seed 2,785,711 $0.000100 $0.01 $0.14 $0.14 1x $0.14 2.73%
To view this company’s complete Cap Table, request access »

InsightRx Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Tempus Venture Capital-Backed Chicago, IL 000 00000 00000000000 00000
000000000 Corporate Backed or Acquired Cambridge, MA 00 000 000000&0 000
00000 000000000 00 Venture Capital-Backed Pittsburgh, PA 00 00.000 000000000 00.000
000000 (0000 00000 Venture Capital-Backed Bangalore, India 000 000.00 0000000000 0 000.00
000000 Venture Capital-Backed San Francisco, CA 00 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

InsightRx Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
HealthX Ventures Venture Capital Minority 000 0000 000000 0
OSF Healthcare Corporation Minority 000 0000 000000 0
Premier Corporation Minority 000 0000 000000 0
Rock Health Venture Capital Minority 000 0000 000000 0
MassChallenge Accelerator/Incubator 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »

InsightRx Executive Team (5)

Name Title Board
Seat
Contact
Info
Srijib Goswami Ph.D Co-Founder & Chief Executive Officer
Ranvir Mangat COO, Pharmacometric Applications
Ron Keizer Ph.D Co-Founder & Chief Scientific Officer
David Carvel Director of Strategy and Business Development
Lena Schneider Technical Advisor

InsightRx Board Members (2)

Name Representing Role Since Contact
Info
Mayank Taneja MD OSF Ventures Board Member 000 0000

1 Former Board Member

You’re viewing 1 of 2 board members. Get the full list »